Form EFFECT Autolus Therapeutics
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 5, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Burco Helps Drivers Lower Repair Costs with Replacement Side View Mirror Glass
- Founder of Witherite Law Group Amy Witherite Warns 19 Different State-Filed Response Plans for Autonomous Vehicles Shows Will Cause More Issues for First Responders
- Industry Veteran Sloan Dean Launches AI Hospitality Group, the First AI-Native Hotel Operating Company
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share